Search

everythinglearnresearchcommunity

for

Search:↓

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Sparse hairs below frontal hairline can indicate early male balding.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

We need better ways to test and understand SARMs to make safer and more effective treatments.